On the other hand, Stathmin1 blockade, like Stat3 overexpression, has been discussed as a potential therapeutic issue to balance microtubule dynamics in neurodegenerative diseases (Gagliardi et al., 2022; Yadav et al., 2016). This evidence concerns the gene STAT3 and neurodegenerative disease.